twitter
en POLSKI
eISSN: 2719-3209
ISSN: 0023-2157
Klinika Oczna / Acta Ophthalmologica Polonica
Current issue Archive Videos Articles in press About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2022
vol. 124
 
Share:
Share:
abstract:
Review article

Ophthalmic applications of cyclopentolate

Anna Chmielarz-Czarnocińska
1
,
Anna Gotz-Więckowska
1

  1. Department of Ophthalmology, Chair of Ophthalmology and Optometry, Poznan University of Medical Sciences, Poznan, Poland
KLINIKA OCZNA 2022; 124, 2: 71-74
Online publish date: 2022/06/14
View full text Get citation
 
PlumX metrics:
Cyclopentolate is a drug that causes paralysis of accommodation and induces mydriasis. It is widely used around the world. In view of its relatively short duration of action and effective induction of cycloplegia, cyclopentolate is particularly useful in screening children for refractive errors. In addition to diagnostic applications, it is also used for therapeutic purposes, e.g. in uveitis. In October 2021, cyclopentolate, which had not been approved in Poland for years, was authorized for marketing.

The authors of the paper reviewed the literature on cyclopentolate. The properties of the drug were analyzed, and its action was compared with other available cycloplegic agents. In addition, the potential uses of cyclopentolate and its special role in facilitating the ophthalmological examination of children were discussed.
keywords:

cyclopentolate, tropicamide, atropine, cycloplegia, refraction assessment after accommodation paralysis, uveitis

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.